Cargando…

The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress

Neuropilin-1 (NRP-1) is a transmembrane glycoprotein. As a VEGF co-receptor, NRP1 significantly enhances VEGFR2 signaling and promotes vascular permeability and migration. The purpose of this study was to evaluate the effects of an NRP-1 inhibitor, ATWLPPR peptide, on the early stages of diabetic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jun, Wang, Shuaiwei, Li, Mengling, Wu, Dongdong, Liu, Fang, Yang, Ruisheng, Ji, Shaoping, Ji, Ailing, Li, Yanzhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640834/
https://www.ncbi.nlm.nih.gov/pubmed/26554379
http://dx.doi.org/10.1371/journal.pone.0142571
_version_ 1782400124841885696
author Wang, Jun
Wang, Shuaiwei
Li, Mengling
Wu, Dongdong
Liu, Fang
Yang, Ruisheng
Ji, Shaoping
Ji, Ailing
Li, Yanzhang
author_facet Wang, Jun
Wang, Shuaiwei
Li, Mengling
Wu, Dongdong
Liu, Fang
Yang, Ruisheng
Ji, Shaoping
Ji, Ailing
Li, Yanzhang
author_sort Wang, Jun
collection PubMed
description Neuropilin-1 (NRP-1) is a transmembrane glycoprotein. As a VEGF co-receptor, NRP1 significantly enhances VEGFR2 signaling and promotes vascular permeability and migration. The purpose of this study was to evaluate the effects of an NRP-1 inhibitor, ATWLPPR peptide, on the early stages of diabetic retinopathy. Eight-week-old male C57BL/6 mice were divided into three groups: a Normal group, a Diabetes (DB) ATWLPPR treatment group and a DB saline group. Electroretinography (ERG), fundus fluorescence angiography (FFA) and leukostasis were examined to evaluate the retinal injury induced by diabetes at the end of the fifth week after STZ injection. Occludin expression and extravasation of albumin were measured to determine the extent of vascular injury. The oxidative stress level and the levels of inflammation-associated proteins were also assayed. The results indicated that treatment with ATWLPPR prevents the abnormal condition of ERG (amplitudes of b-wave decreased and implicit time increased) and vascular injury (occludin degradation and increase in extravasated albumin). These effects were associated with a reduction in the oxidase stress level and the expression of VEGF, GFAP, and ICAM-1. We conclude that ATWLPPR, an NRP-1 inhibitor, may reduce the early retinal damage induced by diabetes by preserving vascular integrity and decreasing the oxidative stress level. Blockade of NRP-1 may be a new therapeutic strategy for the early stages of DR.
format Online
Article
Text
id pubmed-4640834
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46408342015-11-13 The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress Wang, Jun Wang, Shuaiwei Li, Mengling Wu, Dongdong Liu, Fang Yang, Ruisheng Ji, Shaoping Ji, Ailing Li, Yanzhang PLoS One Research Article Neuropilin-1 (NRP-1) is a transmembrane glycoprotein. As a VEGF co-receptor, NRP1 significantly enhances VEGFR2 signaling and promotes vascular permeability and migration. The purpose of this study was to evaluate the effects of an NRP-1 inhibitor, ATWLPPR peptide, on the early stages of diabetic retinopathy. Eight-week-old male C57BL/6 mice were divided into three groups: a Normal group, a Diabetes (DB) ATWLPPR treatment group and a DB saline group. Electroretinography (ERG), fundus fluorescence angiography (FFA) and leukostasis were examined to evaluate the retinal injury induced by diabetes at the end of the fifth week after STZ injection. Occludin expression and extravasation of albumin were measured to determine the extent of vascular injury. The oxidative stress level and the levels of inflammation-associated proteins were also assayed. The results indicated that treatment with ATWLPPR prevents the abnormal condition of ERG (amplitudes of b-wave decreased and implicit time increased) and vascular injury (occludin degradation and increase in extravasated albumin). These effects were associated with a reduction in the oxidase stress level and the expression of VEGF, GFAP, and ICAM-1. We conclude that ATWLPPR, an NRP-1 inhibitor, may reduce the early retinal damage induced by diabetes by preserving vascular integrity and decreasing the oxidative stress level. Blockade of NRP-1 may be a new therapeutic strategy for the early stages of DR. Public Library of Science 2015-11-10 /pmc/articles/PMC4640834/ /pubmed/26554379 http://dx.doi.org/10.1371/journal.pone.0142571 Text en © 2015 Wang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Wang, Jun
Wang, Shuaiwei
Li, Mengling
Wu, Dongdong
Liu, Fang
Yang, Ruisheng
Ji, Shaoping
Ji, Ailing
Li, Yanzhang
The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress
title The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress
title_full The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress
title_fullStr The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress
title_full_unstemmed The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress
title_short The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress
title_sort neuropilin-1 inhibitor, atwlppr peptide, prevents experimental diabetes-induced retinal injury by preserving vascular integrity and decreasing oxidative stress
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640834/
https://www.ncbi.nlm.nih.gov/pubmed/26554379
http://dx.doi.org/10.1371/journal.pone.0142571
work_keys_str_mv AT wangjun theneuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT wangshuaiwei theneuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT limengling theneuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT wudongdong theneuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT liufang theneuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT yangruisheng theneuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT jishaoping theneuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT jiailing theneuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT liyanzhang theneuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT wangjun neuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT wangshuaiwei neuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT limengling neuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT wudongdong neuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT liufang neuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT yangruisheng neuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT jishaoping neuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT jiailing neuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress
AT liyanzhang neuropilin1inhibitoratwlpprpeptidepreventsexperimentaldiabetesinducedretinalinjurybypreservingvascularintegrityanddecreasingoxidativestress